Evidence-gap map · non-drug interventions

Restless Legs Syndrome evidence gaps

57 registered non-drug trials, mapped by approach and outcome.

  1. Research Tracker
  2. Evidence-gap maps
  3. Restless Legs Syndrome

Which non-drug approaches have been tested for Restless Legs Syndrome, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

57registered non-drug trials
4with results posted
7recruiting as of 2026-11-16
40group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Restless Legs Syndrome by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Exercise and physical activity (16)1···25···2··15··1
Rehabilitation and therapy services (1)····11······1···
Mind-body and psychological approaches (3)1···11···1··1·11
Cognitive training and education (4)·····3······1·111 with results
Diet, fasting and nutrition (1)············1···
Sleep and circadian approaches (4)·····41 with results······1·1·
Neuromodulation and electrical stimulation (5)·····1······41 with results1··
Oxygen, light, temperature and manual therapies (14)···216···41110·11
Supplements and nutraceuticals (6)·····1···1·13·11
Other behavioural, not yet classified (5)····11 with results·1·····2··2

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Breathing and respiratory training; Other devices and digital tools; Care delivery and health services.

Where the gaps are

Questions studied but with no results posted

  • Exercise and physical activity × symptom severity and disease activity: 15 trials registered, none with results posted (2 still recruiting)
  • Oxygen, light, temperature and manual therapies × symptom severity and disease activity: 10 trials registered, none with results posted (1 still recruiting)
  • Oxygen, light, temperature and manual therapies × sleep: 6 trials registered, none with results posted
  • Exercise and physical activity × sleep: 5 trials registered, none with results posted (1 still recruiting)
  • Oxygen, light, temperature and manual therapies × quality of life: 4 trials registered, none with results posted (1 still recruiting)
  • Cognitive training and education × sleep: 3 trials registered, none with results posted
  • Supplements and nutraceuticals × symptom severity and disease activity: 3 trials registered, none with results posted

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Restless Legs Syndrome

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 7 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.